Alkermes Plc (NASDAQ:ALKS)

45.03
Data as of Apr 16
 +2.20 / +5.14%
Today’s Change
24.42
Today|||52-Week Range
54.25
+10.75%
Year-to-Date
Alkermes plc (ALKS): New Analyst Report from Zacks Equity Research - Zacks Equity Res...
Apr 16 / Zacks.com
Why Alkermes PLC Shares Temporarily Spiked Higher
Apr 08 / MotleyFool.com
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data -...
Apr 16 / Zacks.com
Alkermes Scores Phase 3 Win for Long-Lasting Schizophrenia Drug
Apr 08 / MotleyFool.com
The Biggest Biotech Wins of the Week
Apr 15 / MotleyFool.com
Halozyme Falls on Phase II Study Halt - Analyst Blog
Apr 08 / Zacks.com
Gilead Sciences (GILD) Falls: Stock Goes Down 7.3% - Tale of the Tape
Apr 11 / Zacks.com
Bristol-Myers Seeks FDA Approval for HCV Candidates - Analyst Blog
Apr 08 / Zacks.com
Halozyme Study Under Clinical Hold - Analyst Blog
Apr 10 / Zacks.com
FDA Target Date for Gilead's HCV Candidate - Analyst Blog
Apr 08 / Zacks.com
ImmunoGen Up on Positive Pipeline Data - Analyst Blog
Apr 10 / Zacks.com
RadNet Touches New 52-Week High - Analyst Blog
Apr 08 / Zacks.com
Gilead Announces Encouraging Sovaldi Data - Analyst Blog
Apr 10 / Zacks.com
Agios Pharmaceuticals (AGIO) Surges: Stock Moves 27.8% Higher - Tale of the Tape
Apr 08 / Zacks.com
3 Top-Ranked Biotech Stocks on the Rebound - Analyst Blog
Apr 10 / Zacks.com
MannKind Slips on Afrezza Approval Delay - Analyst Blog
Apr 08 / Zacks.com
'Mad Money' Lightning Round: Buy, Buy, Buy Baxter
Apr 10 / TheStreet.com
Idenix Pharmaceuticals (IDIX) Jumps: Stock Up 12.4% - Tale of the Tape
Apr 08 / Zacks.com
Oncolytics Reports Additional Data on Reolysin - Analyst Blog
Apr 09 / Zacks.com
Puma Biotechnology (PBYI) in Focus: Stock Tumbles 18.3% - Tale of the Tape
Apr 08 / Zacks.com
Ambit's Oncology Drug in Phase III - Analyst Blog
Apr 09 / Zacks.com
Amgen's Oncology Candidate Disappoints - Analyst Blog
Apr 07 / Zacks.com
Seattle Genetics Earns Milestone Payment - Analyst Blog
Apr 09 / Zacks.com
Glaxo and Amgen Terminate Agreement - Analyst Blog
Apr 04 / Zacks.com
Biotech Stock Roundup: MannKind Soars on Panel Vote, Halozyme Plunges on Safety Conce...
Apr 09 / Zacks.com
Response Genetics (RGDX) in Focus: Stock Up 18.3% - Tale of the Tape
Apr 04 / Zacks.com
Positive Trial Data Lifts Alkermes - Analyst Blog
Apr 09 / Zacks.com
Weakness Seen in Kindred Biosciences (KIN): Stock Tumbles 9.0% - Tale of the Tape
Apr 04 / Zacks.com
Pharmacyclics Files sNDA - Analyst Blog
Apr 09 / Zacks.com
Good News for Keryx - Analyst Blog
Apr 03 / Zacks.com
Sanofi to File for Lemtrada Approval Again - Analyst Blog
Apr 08 / Zacks.com
Glaxo Stops MAGE-A3 Lung Cancer Study - Analyst Blog
Apr 03 / Zacks.com
EPO Upholds Alnylam's McSwiggen Patent - Analyst Blog
Apr 08 / Zacks.com
Encouraging Results on Gilead's Sovaldi - Analyst Blog
Apr 03 / Zacks.com
Merck KGaA Starts Study on Tecemotide - Analyst Blog
Apr 08 / Zacks.com
Acceleron Pharma (XLRN) Jumps: Stock Up 13.2% - Tale of the Tape
Apr 03 / Zacks.com
Encouraging Pre-Clinical Data from Celldex - Analyst Blog
Apr 08 / Zacks.com
Should You Get Rid of Synageva BioPharma (GEVA) Now? - Tale of the Tape
Apr 03 / Zacks.com
Intercept Pharma Prices 1M Share Offering, Shares Down - Analyst Blog
Apr 08 / Zacks.com
RadNet (RDNT) in Focus: Stock Adds 11.8% in Session - Tale of the Tape
Apr 03 / Zacks.com
Pipeline Update from Idenix - Analyst Blog
Apr 08 / Zacks.com
What Falling Estimates & Price Mean for bluebird bio (BLUE) - Tale of the Tape
Apr 03 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.